Physician profile
Michael Mccracken
NPI 1184703431
$2,910.56
in general payments reported to CMS, 2019-2025
10 companies · $401 in 2025
The $401 reported for 2025 was more than what 77% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $306 · 2021: $1,049 · 2022: $341 · 2023: $254 · 2024: $282 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924 · Education: $13.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.96 |
| Education | $13.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $2,138.04 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| A-Dec, INC. | $515.00 | 2021 | |
| Tulsa Dental Products LLC | $126.96 | 2020 | |
| Dentsply Sirona INC | $29.56 | 2023 | Protaper Universal, Waveone Gold Conform Fit |
| 3m Company | $24.78 | 2023 | 3m Relyx, Scotchbond Universal Plus, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Zest Holdings, LLC | $19.42 | 2020 | |
| Envista Holdings Corporation | $16.65 | 2024 | Maxcem Elite |
| Straumann USA LLC | $14.84 | 2021 | |
| Septodont INC. | $13.10 | 2024 | Biodentine |
| Kerr Corporation | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.